Ching‐I Huang

1.7k total citations
87 papers, 956 citations indexed

About

Ching‐I Huang is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Ching‐I Huang has authored 87 papers receiving a total of 956 indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Epidemiology, 72 papers in Hepatology and 9 papers in Surgery. Recurrent topics in Ching‐I Huang's work include Liver Disease Diagnosis and Treatment (69 papers), Hepatitis C virus research (62 papers) and Hepatitis B Virus Studies (41 papers). Ching‐I Huang is often cited by papers focused on Liver Disease Diagnosis and Treatment (69 papers), Hepatitis C virus research (62 papers) and Hepatitis B Virus Studies (41 papers). Ching‐I Huang collaborates with scholars based in Taiwan, United States and Mongolia. Ching‐I Huang's co-authors include Chia‐Yen Dai, Ming‐Lung Yu, Chung‐Feng Huang, Ming‐Lun Yeh, Wan‐Long Chuang, Jee‐Fu Huang, Zu‐Yau Lin, Ming‐Yen Hsieh, Meng‐Hsuan Hsieh and Shinn‐Cherng Chen and has published in prestigious journals such as PLoS ONE, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Ching‐I Huang

85 papers receiving 944 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ching‐I Huang Taiwan	15	747	659	111	81	78	87	956
Jeng‐Fu Yang Taiwan	17	813 1.1×	685 1.0×	160 1.4×	78 1.0×	52 0.7×	41	998
Shinn‐Chern Chen Taiwan	17	672 0.9×	612 0.9×	148 1.3×	74 0.9×	80 1.0×	38	831
Xiangjun Jiang China	12	891 1.2×	767 1.2×	82 0.7×	40 0.5×	58 0.7×	15	1.1k
Mircea Grigorescu Romania	20	1.0k 1.4×	871 1.3×	95 0.9×	52 0.6×	97 1.2×	47	1.3k
Luca Marzi Italy	9	565 0.8×	481 0.7×	71 0.6×	50 0.6×	67 0.9×	19	720
Ilaria Serio Italy	9	570 0.8×	366 0.6×	197 1.8×	73 0.9×	82 1.1×	21	750
Angeline Oi–Shan Lo Hong Kong	13	943 1.3×	730 1.1×	137 1.2×	75 0.9×	48 0.6×	22	1.2k
Gi‐Ae Kim South Korea	16	1.3k 1.7×	1.1k 1.7×	144 1.3×	98 1.2×	117 1.5×	43	1.5k
Kazuyuki Ohata Japan	9	538 0.7×	382 0.6×	103 0.9×	50 0.6×	101 1.3×	16	766
Hidekatsu Kuroda Japan	18	597 0.8×	574 0.9×	48 0.4×	56 0.7×	50 0.6×	82	890

Countries citing papers authored by Ching‐I Huang

Since Specialization

Citations

This map shows the geographic impact of Ching‐I Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching‐I Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching‐I Huang more than expected).

Fields of papers citing papers by Ching‐I Huang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ching‐I Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching‐I Huang. The network helps show where Ching‐I Huang may publish in the future.

Co-authorship network of co-authors of Ching‐I Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Ching‐I Huang. A scholar is included among the top collaborators of Ching‐I Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ching‐I Huang. Ching‐I Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yeh, Ming‐Lun, Chia‐Yen Dai, Chung‐Feng Huang, et al.. (2024). The efficacy of multi‐disciplinary lifestyle modifications in Taiwanese nonalcoholic steatohepatitis patients. The Kaohsiung Journal of Medical Sciences. 40(6). 575–582. 1 indexed citations

Huang, Jee‐Fu, Pei‐Chien Tsai, Ming‐Lun Yeh, et al.. (2023). Community-centered Disease Severity Assessment of Metabolic Dysfunction-associated Fatty Liver Disease. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 3 indexed citations

Lee, Kuan‐I, Po‐Cheng Liang, Po‐Yao Hsu, et al.. (2023). Unawareness of hepatitis B infection and lack of surveillance are associated with severity of hepatocellular carcinoma. The Kaohsiung Journal of Medical Sciences. 39(11). 1145–1154. 2 indexed citations

Huang, Chung‐Feng, Po‐Cheng Liang, Pei‐Chien Tsai, et al.. (2023). The interplay of metabolic dysfunction‐associated fatty liver disease and viral hepatitis on liver disease severity: A large community‐based study in a viral endemic area. Journal of Gastroenterology and Hepatology. 39(1). 193–201. 4 indexed citations

Hsu, Po‐Yao, Po‐Cheng Liang, Ching‐I Huang, et al.. (2022). Effects of Achieving SVR on Clinical Characteristics and Surgical Outcomes in Patients Who Developed Early-Stage HCV-Related Hepatocellular Carcinoma and Received Curative Resection: Preoperative versus Postoperative SVR. Viruses. 14(11). 2412–2412. 3 indexed citations

Tsai, Yi‐Shan, Ching‐I Huang, Pei‐Chien Tsai, et al.. (2022). Circulating Let-7 Family Members as Non-Invasive Biomarkers for Predicting Hepatocellular Carcinoma Risk after Antiviral Treatment among Chronic Hepatitis C Patients. Cancers. 14(8). 2023–2023. 6 indexed citations

Tsai, Pei‐Chien, Chia‐Yen Dai, Ching‐I Huang, et al.. (2022). Low disease awareness as a contributing factor to the high prevalence of hepatitis C infection in Tzukuan, a hyperendemic area of southern Taiwan. The Kaohsiung Journal of Medical Sciences. 38(7). 694–702. 2 indexed citations

Jang, Tyng‐Yuan, Yi‐Hung Lin, Po‐Cheng Liang, et al.. (2022). Amelioration of glucose intolerance through directly acting antiviral agents in chronic hepatitis C cirrhotic patients without overt diabetes. The Kaohsiung Journal of Medical Sciences. 38(9). 897–906. 4 indexed citations

Huang, Ching‐I, Ming‐Lun Yeh, Chung‐Feng Huang, et al.. (2022). Persistent cryoglobulinemia after antiviral treatment is associated with advanced fibrosis in chronic hepatitis C patients. PLoS ONE. 17(5). e0268180–e0268180. 4 indexed citations

10.

Yeh, Ming‐Lun, Po‐Cheng Liang, Sam Trinh, et al.. (2021). Body weight changes in treated hepatitis B patients switching to tenofovir alafenamide☆. Journal of the Formosan Medical Association. 121(7). 1273–1282. 6 indexed citations

11.

Lin, Zu‐Yau, Ming‐Lun Yeh, Ching‐I Huang, et al.. (2021). Limited sorafenib anticancer effects on primary cultured hepatocellular carcinoma cells with high NANOG expression. The Kaohsiung Journal of Medical Sciences. 38(2). 157–164. 1 indexed citations

12.

Jang, Tyng‐Yuan, Chung‐Feng Huang, Ming‐Lun Yeh, et al.. (2021). Serum Wisteria floribunda agglutinin‐positive Mac‐2‐binding protein expression predicts disease severity in nonalcoholic steatohepatitis patients. The Kaohsiung Journal of Medical Sciences. 38(3). 261–267. 5 indexed citations

13.

Tsai, Yi‐Shan, Ming‐Lun Yeh, Pei‐Chien Tsai, et al.. (2020). Clusters of Circulating let-7 Family Tumor Suppressors Are Associated with Clinical Characteristics of Chronic Hepatitis C. International Journal of Molecular Sciences. 21(14). 4945–4945. 9 indexed citations

14.

Huang, Chung‐Feng, Ming‐Lun Yeh, Ching‐I Huang, et al.. (2019). Ribavirin facilitates early viral kinetics in chronic hepatitis C patients receiving daclatasvir/asunaprevir. Journal of Gastroenterology and Hepatology. 35(1). 151–156. 6 indexed citations

15.

Huang, Ching‐I, Ming‐Lun Yeh, Chung‐Feng Huang, et al.. (2018). Association between cryoglobulinemia and liver fibrosis in chronic hepatitis C patients. Journal of Gastroenterology and Hepatology. 33(11). 1897–1903. 8 indexed citations

16.

Huang, Chung‐Feng, Ming‐Lun Yeh, Ching‐I Huang, et al.. (2017). Interference of hepatitis B virus dual infection in platelet count recovery in chronic hepatitis C patients with curative antiviral therapy. Journal of Gastroenterology and Hepatology. 33(5). 1108–1114. 5 indexed citations

17.

Yen, Ming‐Hong, Ching‐I Huang, Min‐Sheng Lee, et al.. (2017). Artemisia capillaris inhibited enterovirus 71‐induced cell injury by preventing viral internalization. The Kaohsiung Journal of Medical Sciences. 34(3). 150–159. 8 indexed citations

18.

Yu, Ming‐Lung, Chung‐Feng Huang, Ming‐Lun Yeh, et al.. (2016). Time-Degenerative Factors and the Risk of Hepatocellular Carcinoma after Antiviral Therapy among Hepatitis C Virus Patients: A Model for Prioritization of Treatment. Clinical Cancer Research. 23(7). 1690–1697. 26 indexed citations

19.

Tsai, Pei‐Chien, Ta‐Wei Liu, Meng‐Hsuan Hsieh, et al.. (2016). A real‐world impact of cost‐effectiveness of pegylated interferon/ribavarin regimens on treatment‐naïve chronic hepatitis C patients in Taiwan. The Kaohsiung Journal of Medical Sciences. 33(1). 44–49. 9 indexed citations

20.

Yeh, Ming‐Lun, Ching‐I Huang, Ming‐Yen Hsieh, et al.. (2016). Lamivudine switch therapy in chronic hepatitis B patients achieving undetectable hepatitis B virus DNA after 3 years of entecavir therapy: A prospective, open‐label, multicenter study. The Kaohsiung Journal of Medical Sciences. 32(11). 559–566. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact